ERBB2 and breast carcinoma: lncRNA-SNHG14 incorporated into exosomes from trastuzumab-resistant HER-2+ breast cancer cells can disseminate resistance to sensitive cells by targeting the apoptosis regulator Bcl-2 (Bcl-2) signaling pathway [61].